PURPOSE: Cross-sectional study to validate a Spanish version of the 5 and 15 items Geriatric Depression Scale (GDS 5 and 15) in a non-selected community dwelling older population, compared with the clinical diagnosis of depression (using DSM-IV criteria) as gold standard. PATIENTS AND METHOD: A total of 301 subjects randomly selected from the >64 years old population served by a public Primary Care Center in Madrid were included. Severe cognitive impairment (MMSE < 20/30), severe hearing impairment and denial to participate were exclusion criteria. A descriptive and a screening study were performed. RESULTS: The prevalence of depression in this population was 14.6%. The 5- item GDS had a sensitivity of 0.864 (0.762-0.965), specificity of 0.856 (0.813-0.899), PPV 0.507 (0.394-0.62), NPV 0.973 (0.952-0.994), and positive likelihood ratio 6 (4.34-8.26). The 15-item GDS had a sensitivity of 0.818 (0.704-0.932), specificity of 0.977 (0.958-0.995), PPV 0.857 (0.751-0.963), NPV 0.969 (0.948-0.99), and positive likelihood ratio 35.03 (28.76-40.77). CONCLUSIONS: GDS-5 may be useful screening test for depression in non selected elderly patients in primary care. It has better sensitivity than GDS-15 and similar area under curve.
PURPOSE: Cross-sectional study to validate a Spanish version of the 5 and 15 items Geriatric Depression Scale (GDS 5 and 15) in a non-selected community dwelling older population, compared with the clinical diagnosis of depression (using DSM-IV criteria) as gold standard. PATIENTS AND METHOD: A total of 301 subjects randomly selected from the >64 years old population served by a public Primary Care Center in Madrid were included. Severe cognitive impairment (MMSE < 20/30), severe hearing impairment and denial to participate were exclusion criteria. A descriptive and a screening study were performed. RESULTS: The prevalence of depression in this population was 14.6%. The 5- item GDS had a sensitivity of 0.864 (0.762-0.965), specificity of 0.856 (0.813-0.899), PPV 0.507 (0.394-0.62), NPV 0.973 (0.952-0.994), and positive likelihood ratio 6 (4.34-8.26). The 15-item GDS had a sensitivity of 0.818 (0.704-0.932), specificity of 0.977 (0.958-0.995), PPV 0.857 (0.751-0.963), NPV 0.969 (0.948-0.99), and positive likelihood ratio 35.03 (28.76-40.77). CONCLUSIONS: GDS-5 may be useful screening test for depression in non selected elderly patients in primary care. It has better sensitivity than GDS-15 and similar area under curve.
Authors: Juan Carlos Torre-Alonso; Loreto Carmona; Mireia Moreno; Eva Galíndez; Jesús Babío; Pedro Zarco; Luis Linares; Eduardo Collantes-Estevez; Manuel Fernández Barrial; Juan Carlos Hermosa; Pablo Coto; Carmen Suárez; Raquel Almodóvar; Jesús Luelmo; Santos Castañeda; Jordi Gratacós Journal: Rheumatol Int Date: 2017-04-07 Impact factor: 2.631
Authors: Daniel S Reuland; Andrea Cherrington; Garth S Watkins; Daniel W Bradford; Roberto A Blanco; Bradley N Gaynes Journal: Ann Fam Med Date: 2009 Sep-Oct Impact factor: 5.166
Authors: Paulo Ruiz-Grosso; Christian Loret de Mola; Johann M Vega-Dienstmaier; Jorge M Arevalo; Kristhy Chavez; Ana Vilela; Maria Lazo; Julio Huapaya Journal: PLoS One Date: 2012-10-08 Impact factor: 3.240
Authors: Sergi Blancafort Alias; Rosa Monteserín Nadal; Irene Moral; Marta Roqué Fígols; Xavier Rojano I Luque; Laura Coll-Planas Journal: BMC Public Health Date: 2021-01-07 Impact factor: 3.295